Toripalimab, Induction Chemotherapy, Radiation Therapy With Omega-3 for Locally Advanced Nasopharyngeal Carcinoma

PHASE2Not yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 22, 2025

Primary Completion Date

December 31, 2029

Study Completion Date

December 31, 2029

Conditions

Nasopharyngeal Carcinoma (NPC)

Interventions

DRUG

Toripalimab

240mg Q3W

DIETARY_SUPPLEMENT

Omega-3

During radiotherapy, take 6 capsules once a day

RADIATION

radiotherapy

DRUG

Paclitaxel (albumin bound)

260mg/m2 d1,Q3W

DRUG

Cisplatin

80mg/m2 d2, Q3W

All Listed Sponsors

lead

Affiliated Hospital of Guangdong Medical University

OTHER